Intelligence, benchmarking, and certification for risk and compliance leaders, from the institution setting the standard since 1922.
Edwards Lifesciences Corp. will pay a $10 million penalty and create and maintain an antitrust compliance program under a pending agreement with the U.S. Federal Trade Commission (FTC) for failing to notify the commission about its acquisition of JC Medical from Genesis MedTech Group.
Adrianne Appel writes regulatory news, policy, and trends for Compliance Week. She previously reported about policy developments for Bloomberg Law and Bloomberg Government. Email: adrianne.appel@complianceweek.com LinkedIn:... More by Adrianne Appel
We'll send a verification code to %EMAIL%.
